#141 – Jim Poole, President & CEO at Solace Lifesciences (NuCalm)

Share This Post

Watch

Listen

Episode Details

Our guest: Jim Poole, President & CEO at Solace Lifesciences (flagship product = NuCalm).

“NuCalm is a revolutionary technology proven to remediate chronic stress at the midbrain level.  The NuCalm system uses 4 components to provide a biological mimic of the same neural pathways the body uses to enter the first stage of sleep.”

In this episode, we discussed:

  • His background
  • What is NuCalm?
  • How does NuCalm work? 
  • Who uses NuCalm? 
  • …and much more!

WORD FROM OUR SPONSORS:

Our sponsors for this episode are BlocHealthCuration Health & ChenMed

BlocHealth is building the ecosystem of services and solutions to power the future of healthcare. For more information, please go to www.blochealth.com and be sure to follow BlocHealth on social media – @blochealth


“Curation Health’s advanced clinical decision support platform seamlessly integrates into the electronic health record and leverages more than 750 proven clinical and quality rules. With this intelligent point-of-care platform, you can power a scalable risk adjustment process and amplify quality program performance.” For more information, please go to www.curationhealthcare.com and be sure to follow Curation Health on social media – @curationhealth


“ChenMed brings concierge-style medicine and better health outcomes to the neediest populations – moderate-to-low income seniors with complex chronic diseases. Operating over 50 medical centers in eight states, we are known to our patients as Dedicated Senior Medical Center, Chen Senior Medical Center, or JenCare Senior Medical Center.” For more information, please go to www.chenmed.com and be sure to follow ChenMed on social media – @chenmed


To learn more about Solace Life Sciences (NuCalm) please use the links below:

– Website – LinkedIn – Twitter – Facebook – Instagram – YouTube

Also, be sure to follow Slice of Healthcare on our social channels:

– Website – Facebook – LinkedIn – Twitter – YouTube – Newsletter

More To Explore

Total
0
Share